Shares of HCL Technologies declined by 2.01% to Rs 1,587.20 in early trade on Tuesday. The stock's performance is in ...

AstraZeneca Pharma India has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India to import for sale and ...

HCLTech’s muted Q1 and lower margin guidance have raised investor concerns. While revenue guidance has improved slightly, ...

Indian benchmark indices, Sensex and Nifty, are expected to get off to a muted start on Tuesday, as indicated by GIFT Nifty, ...

On Thursday, July 10, TCS announced a 6% increase in its net profit for the June quarter, reaching ₹ 12,760 crore. In the ...

Indian stocks may find relief from recent losses, with focus on HCL Technologies and potential regulatory changes.

Indian equity indices, Sensex and Nifty, are expected to open on flat-to-higher note on Tuesday following positive global ...

Shares of HCL Technologies will be in focus after the IT major reported weaker-than-expected June quarter results ...

Nuvama cuts HCL Tech to 'Hold' after weak Q1 margins and lowered guidance—see what this means for investors now.

HCL Technologies reported a 10% YoY decline in consolidated net profit for Q1FY26, falling below Street estimates, while revenue rose 8% YoY. The company declared an interim dividend of Rs 12 per ...

HCL Technologies saw a 10 percent fall in consolidated net profit at Rs 3,843 crore for Q1FY26, as against Rs 4,257 crore in ...

HCLTech revised its margin guidance for the full-year down to 17% to 18% from 18% to 19% earlier. On the flip side the ...